🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of Drug-El...
Status
Completed
Location
Seoul National Universtiy Bundang Hospital
Start Date
2011-04
Trial ID
NCT01539603
Treatments Being Tested
Drug-eluting stent (DES)-based primary percutaneous intervention (pPCI) has...
Status
Recruiting
Location
Universitatsklinikum AKH wien
Start Date
2026-02-08
Trial ID
NCT07436429
Treatments Being Tested
Randomized, open-label, single-center, non-inferiority clinical trial to co...
Status
Unknown
Location
Military hospital of Tunis
Start Date
2021-08-25
Trial ID
NCT05516446
Treatments Being Tested
A Prospective Randomized, Multi-centre, International, Open Label, Clinical...
Status
Active Not Recruiting
Location
Academic Teaching Hospital Feldkirch
Start Date
2021-05-15
Trial ID
NCT04859985
Treatments Being Tested
Prospective, randomized controlled, single-blind, multicenter, clinical tri...
Status
Recruiting
Location
St. Bernards
Start Date
2023-10-20
Trial ID
NCT05946629
Treatments Being Tested
This Clinical Evaluation Report (CER) covers the Mamba Sirolimus-Eluting PT...
Status
Completed
Location
Prime Heart Institute
Start Date
2023-01-11
Trial ID
NCT07326735
Significant lesions in small coronary arteries are frequently found (35%-50...
Status
Completed
Location
Hospital Universitario Álvaro Cunqueiro
Start Date
2012-12
Trial ID
NCT01722799
Treatments Being Tested
Randomized, single-blind, single-center, non-inferiority clinical trial to ...
Status
Terminated
Location
Instituto Nacional de Cardiologia "Ignacio Chávez"
Start Date
2021-04-20
Trial ID
NCT04885816
Treatments Being Tested
The goal of this clinical trial is to compare the use of a specific drug el...
Status
Recruiting
Location
Marco Valgimigli
Start Date
2023-02-21
Trial ID
NCT05674630
Treatments Being Tested